Tropicamide Eye Drops

Description

Tropicamide Ophthalmic Solution (1% w/v)

Healthy Inc is a specialized global supplier and exporter of advanced diagnostic ophthalmology and targeted ocular therapeutics. We provide ultra-high-purity, kinetically stabilized Tropicamide Eye Drops, manufactured in WHO–GMP certified, high-precision sterile ophthalmic facilities. This “Anticholinergic Mydriatic” is a massive-volume strategic export to diagnostic eye centers, surgical hospitals, and government health ministries, serving as the globally mandated intervention for inducing pupil dilation and paralysis of accommodation during clinical examinations.

Product Overview

This formulation operates as a “Neuromuscular Interrupter.” It physically blocks the chemical signals that tell the eye to constrict the pupil or focus on near objects, allowing the physician to see deep into the internal structures of the eye.

• Mechanism 1 (Muscarinic Receptor Blockade): Tropicamide physically binds to and blocks the Muscarinic (M3) receptors in the iris sphincter muscle and the ciliary body.

• Mechanism 2 (Active Mydriasis): By blocking these receptors, it physically prevents the pupil from constricting in response to light, leading to wide-open dilation (Mydriasis) within 20–40 minutes.

• Mechanism 3 (Cycloplegia): It physically paralyzes the ciliary muscle, preventing the eye from “accommodating” or focusing. This is essential for accurate refractive error measurements (Cycloplegic Refraction).

Product Composition & Strength

We supply this product in a Sterile, Buffered, Isotonic Aqueous Solution, optimized for rapid onset and patient comfort.

Technical & Logistics Specifications

• HS Code: 3004.90.99 (Medicaments acting on the sensory organs / Ophthalmic)

• CAS Number: 1508-75-4 (Tropicamide)

• Dosage Form: Sterile Eye Drops (Ophthalmic Solution)

• Packaging: Sterile LDPE Dropper Bottles (5ml). Our specialized ophthalmic packaging ensures 24-month stability in Zone IVb tropical climates.

Manufacturing Authority & Compliance

• Aseptic Filling Excellence: Our manufacturing process utilizes Class 100 (ISO 5) Sterile Filling Lines. This ensures the solution is 100% free from microbial contaminants, a critical requirement for a product used in daily clinical diagnostic settings.

• Onset Optimization: We utilize Advanced pH Management to ensure the Tropicamide molecules remain in a state that allows for the fastest possible corneal penetration, minimizing patient wait times in busy clinics.

Primary Indications

• Diagnostics: Inducing Mydriasis for funduscopy and retinal examinations.

• Refraction: Inducing Cycloplegia to measure true refractive error in pediatric and adult patients.

• Surgery: Pre-operative and post-operative management in certain ocular procedures to prevent synechiae (adhesion of the iris).

Dosage & Administration

• For Mydriasis: Typically 1 or 2 drops 15–20 minutes before the examination.

• For Refraction: Typically 1 or 2 drops repeated after 5 minutes; the examination is performed 20–30 minutes later.

• Administration: Apply to the conjunctival sac. To minimize systemic absorption (especially in children), apply pressure to the tear duct for 1 minute after instillation.

Safety Warning: For Ophthalmic Use Only. Vision Warning: Patients will experience severe light sensitivity and blurred vision for 4 to 6 hours; driving is strictly prohibited until pupils return to normal. Glaucoma Warning: Use with extreme caution in patients with narrow-angle glaucoma as it may trigger an acute attack. Contraindication: Do not use if known hypersensitivity to Tropicamide or belladonna alkaloids exists.

Global Export & Contract Manufacturing

Healthy Inc is a premier Diagnostic Ophthalmic Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-volume sterile diagnostic eye drops. Whether you are a National Diagnostic Network in the Middle East or a B2B Pharma Marketplace partner in Africa, the CIS, or SE Asia, we ensure secure, WHO-GMP compliant delivery.